Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 33.36% to -9 cents per share on November 05

Q3'26

Est.

$-0.09

Q2'26

Missed

by $0.03

Q1'26

Missed

by $0.07

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.01

The last earnings report on August 13 showed earnings per share of -14 cents, missing the estimate of -10 cents. With 3.61M shares outstanding, the current market capitalization sits at 280.02M.

View a ticker or compare two or three

IVVD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for IVVD